CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 7,356	$ 9,676
Short-term investments	0	774
Accounts receivable (net of allowance for doubtful accounts of $89 in 2020 and $86 in 2019)	8,422	6,778
Inventories (excludes inventories of $2,081 in 2020 and $1,480 in 2019 classified in Other assets - see Note 6)	6,128	5,978
Other current assets	4,671	4,277
Total current assets	26,577	27,483
Investments	1,372	1,469
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,572 in 2020 and $17,686 in 2019	16,919	15,053
Goodwill	20,248	19,425
Other Intangibles, Net	16,677	14,196
Other Assets	8,007	6,771
Total Assets	89,800	84,397
Current Liabilities
Loans payable and current portion of long-term debt	2,420	3,610
Trade accounts payable	3,744	3,738
Accrued and other current liabilities	11,690	12,549
Income taxes payable	984	736
Dividends payable	1,567	1,587
Total current liabilities	20,405	22,220
Long-Term Debt	26,321	22,736
Deferred Income Taxes	1,777	1,470
Other Noncurrent Liabilities	12,027	11,970
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2020 and 2019	1,788	1,788
Other paid-in capital	39,489	39,660
Retained earnings	51,107	46,602
Accumulated other comprehensive loss	(6,383)	(6,193)
Stockholders' equity before deduction for treasury stock	86,001	81,857
Less treasury stock, at cost: 1,047,343,390 shares in 2020 and 1,038,087,496 shares in 2019	56,815	55,950
Total Merck & Co., Inc. stockholders’ equity	29,186	25,907
Noncontrolling Interests	84	94
Total equity	29,270	26,001
Liabilities and Equity	$ 89,800	$ 84,397